10031-RT-02 Results of reactor-based BNCT for 44 cases of recurrent and refractory high-grade meningiomas and road to accelerator based BNCT

Introduction: High-grade meningioma (HGM) is difficult clinical entity to treat. Especially recurrent HGM after some radiotherapy has very miserable prognosis. For example median overall survival (mOS) of recurrent HGM after radiotherapy is reported as 2 years. We applied tumor-selective particle ra...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurooncol Adv
Autors principals: Miyatake, Shin-Ichi, Kawabata, Shinji, Wanibuchi, Masahiko, Takai, Satoshi, Takeuchi, Koji, Ono, Koji, Ko, Naonori, Sakurai, Yoshinori, Tanaka, Hiroki, Suzuki, Minoru
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Supplement Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7699070/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa143.047
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars